155 related articles for article (PubMed ID: 37430177)
21. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
22. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer.
Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646
[TBL] [Abstract][Full Text] [Related]
23. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
25. Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.
Stephens AJ; Kennard JA; Fitzsimmons CK; Manyam M; Kendrick JE; Singh C; McKenzie ND; Ahmad S; Holloway RW
Int J Gynecol Cancer; 2020 Mar; 30(3):305-310. PubMed ID: 31857439
[TBL] [Abstract][Full Text] [Related]
26. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer.
Van Trappen P
Surg Oncol; 2022 May; 41():101745. PubMed ID: 35358912
[TBL] [Abstract][Full Text] [Related]
27. Comparing carbon nanoparticles and indocyanine green for sentinel lymph node mapping in endometrial cancer: A randomized-controlled single-center trial.
He M; Liang S; Deng H; Zhang G; Wang Z; Yang X; Wang Y; Li Y; Sun X; Wang J
J Surg Oncol; 2023 Aug; 128(2):332-343. PubMed ID: 37027324
[TBL] [Abstract][Full Text] [Related]
28. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
[TBL] [Abstract][Full Text] [Related]
29. Cervical re-injection of indocyanine green to improve sentinel lymph node detection in endometrial cancer.
Maramai M; Achilarre MT; Aloisi A; Betella I; Bogliolo S; Garbi A; Maruccio M; Quatrale C; Aletti GD; Mariani A; Colombo N; Maggioni A; Multinu F; Zanagnolo V
Gynecol Oncol; 2021 Jul; 162(1):38-42. PubMed ID: 33906784
[TBL] [Abstract][Full Text] [Related]
30. A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Wang T; Hu Y; He Y; Sun P; Guo Z
Arch Gynecol Obstet; 2019 May; 299(5):1429-1435. PubMed ID: 30747328
[TBL] [Abstract][Full Text] [Related]
31. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
32. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
[TBL] [Abstract][Full Text] [Related]
34. Combining Indocyanine Green and Tc
Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
[TBL] [Abstract][Full Text] [Related]
35. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
36. Hysteroscopic endometrial tumor localization and sentinel lymph node mapping. An upgrade of the hysteroscopic role in endometrial cancer patients.
Capozzi VA; Armano G; Maglietta G; Rosati A; Vargiu V; Scarpelli E; Sozzi G; Chiantera V; Cosentino F; Gioè A; Catena U; Scambia G; Fanfani F; Di Spiezio Sardo A; Ghi T; Berretta R
Eur J Surg Oncol; 2023 Oct; 49(10):106952. PubMed ID: 37328309
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node intraoperative analysis in endometrial cancer.
Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
[TBL] [Abstract][Full Text] [Related]
40. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
Khoury-Collado F; St Clair C; Abu-Rustum NR
Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]